Skip to content
ClinCalc Pro
Menu
Cyanide antidote (chelator)

Dicobalt edetate

Brand names: Kelocyanor

Dicobalt edetate is a cobalt-based chelating antidote used for severe, life-threatening cyanide poisoning.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

The cobalt moiety binds cyanide ions to form stable, relatively non-toxic cobalt-cyanide complexes that are excreted, removing cyanide from the circulation.

Prescribing in practice

  • Reserve strictly for confirmed or strongly suspected severe cyanide poisoning, as it is itself toxic and can cause serious reactions (including hypotension and facial/laryngeal oedema) if given in the absence of cyanide.
  • Administer only by clinicians familiar with its use, with full resuscitation facilities immediately available.
  • Follow with supportive care and consider intravenous glucose, as recommended in current prescribing references.

Monitoring

Monitor cardiovascular status, airway and clinical response continuously during and after administration.

Counselling the patient

  • Explain to the team that this is an emergency antidote for cyanide poisoning.
  • Highlight the risk of severe adverse reactions if cyanide exposure is not actually present.
  • Ensure resuscitation equipment is to hand before use.

Evidence & guidelines

Dicobalt edetate is recognised as an antidote for severe cyanide poisoning, with use guided by national poisons information services such as TOXBASE.

Reference: TOXBASE / NPIS; AAGBI; SmPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

Dicobalt edetate is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.